tiprankstipranks
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
US Market
TELO
Telomir Pharmaceuticals, Inc.
RESEARCH TOOLSreports
Want to see TELO full AI Analyst Report?

Telomir Pharmaceuticals, Inc. (TELO) Revenue

208 Followers
StatisticsMarket CapRevenue

Telomir Pharmaceuticals, Inc. Revenue

Telomir Pharmaceuticals, Inc. had a revenue of 0.00 in the quarter ending Dec 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Telomir Pharmaceuticals, Inc. had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
1
Market Cap
$48.13M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
―――
Dec 31, 2024
―――
Dec 31, 2023
―――
Dec 31, 2022
―――
Dec 31, 2021
―――